acrolein has been researched along with 2'-benzoyloxycinnamaldehyde in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (47.62) | 29.6817 |
2010's | 11 (52.38) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Han, DC; Jeon, SB; Kim, HC; Kim, HM; Kim, JM; Kwon, BM; Lee, MY; Shin, KD; Son, KH | 1 |
Kim, SY; Lee, CH; Lee, KJ; Shin, YH | 1 |
Kwon, BM; Lee, CH; Lee, KJ; Shan, R | 1 |
Kim, HC; Kim, HM; Kim, JM; Kwon, BM; Lee, JH; Lee, MR; Moon, EY; Wang, AG; Yu, DY | 1 |
Hwang, EI; Kang, TH; Kim, SU; Kwon, BM; Park, KD; Shin, CS; Yun, BS | 1 |
Chung, YM; Kim, HJ; Kim, JS; Lee, CY; Yoo, YD | 1 |
Kang, JS; Kim, HM; Kim, K; Kwon, BM; Kwon, MG; Lee, CW; Lee, K; Lee, KS; Oh, SJ; Park, SK; Ryu, J | 1 |
Bradshaw, TD; Chua, YS; Franks, M; Gan, FF; Hagen, T; Palaniappan, P; Poobalasingam, T; Scarmagnani, S; Westwell, AD | 1 |
Ha, HL; Han, DC; Han, JM; Jeong, TS; Kwon, BM; Lee, HS; Lee, SY; Moon, EY; Yeom, YI; Yu, DY | 1 |
Kang, JS; Kim, HM; Kim, K; Kwon, BM; Kwon, MG; Lee, CW; Lee, K; Lee, KS; Oh, SJ; Park, SK; Ryu, J; Yu, HE | 1 |
Hong, SH; Ismail, IA; Kwon, BM; Lee, HA; Lee, HJ; Lee, WH; Ock, J; Suk, K | 1 |
Hong, SH; Ismail, IA; Kang, HS; Kwon, BM; Lee, HJ | 1 |
Ahn, SG; Hong, SH; Kim, SA; Kwon, BM; Kwon, JY; Park, SD; Yoon, JH | 1 |
Hong, SH; Kang, HS; Kwon, BM; Lee, HJ; Lee, YJ; Ock, J | 1 |
Chew, EH; Gan, FF; Jones, G; Nagle, AA; So, CL; Wells, G | 1 |
Chang, H; Hong, SH; Ismail, IA; Kang, HS; Kim, HS; Kim, NH; Kwon, BM; Lee, CW; Lee, HJ; Yook, JI; Yun, J | 1 |
Hong, SH; Kang, HS; Kim, J; Kwon, BM; Lee, CW; Lee, HJ; Lee, YJ; Shin, JH; Yun, J | 1 |
Han, E; Kwon, B; Kwon, BM; Lee, D; Park, S; Yang, W; Yoo, W | 1 |
Abdel Shakor, AB; Hong, SH; Ismail, IA | 1 |
Chang, JH; Jeong, H; Kang, SG; Kim, HS; Kim, NH; Lee, JE; Park, J; Shim, JK; Yook, JI | 1 |
ArefNezhad, R; Davoodvandi, A; Mirzaei, H; Moghadam, SA; Pourhanifeh, MH; Sadeghi, S; Sahebkar, A; Sahebnasagh, R; Sharifi, N | 1 |
1 review(s) available for acrolein and 2'-benzoyloxycinnamaldehyde
Article | Year |
---|---|
Anti-cancer effects of cinnamon: Insights into its apoptosis effects.
Topics: Acrolein; Animals; Antineoplastic Agents; Apoptosis; Benzoates; Cell Line, Tumor; Cinnamomum zeylanicum; Eugenol; Humans; Plant Extracts | 2019 |
20 other study(ies) available for acrolein and 2'-benzoyloxycinnamaldehyde
Article | Year |
---|---|
2'-benzoyloxycinnamaldehyde induces apoptosis in human carcinoma via reactive oxygen species.
Topics: Acetylcysteine; Acrolein; Aldehydes; Alkyl and Aryl Transferases; Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Benzoates; Blotting, Western; Carcinoma; Caspase 3; Caspases; Cell Cycle; Cell Line, Tumor; DNA; DNA Fragmentation; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; ErbB Receptors; Farnesyltranstransferase; Flow Cytometry; Genes, p53; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Oxidative Stress; Phosphorylation; Poly(ADP-ribose) Polymerases; Precipitin Tests; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Time Factors | 2004 |
Physicochemical properties of 2'-benzoyloxycinnamaldehyde.
Topics: Acrolein; Benzoates; Drug Stability; Hydrogen-Ion Concentration; Solubility | 2004 |
Protein binding characteristics of 2'-benzoyloxycinnamaldehyde.
Topics: Acrolein; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antineoplastic Agents; Benzoates; Diazepam; Dose-Response Relationship, Drug; GABA Modulators; Humans; Immunoglobulin G; Kinetics; Orosomucoid; Phenylbutazone; Protein Binding; Serum Albumin; Temperature; Warfarin | 2005 |
Delayed occurrence of H-ras12V-induced hepatocellular carcinoma with long-term treatment with cinnamaldehydes.
Topics: Acrolein; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Benzoates; Carcinoma, Hepatocellular; Cell Proliferation; Female; Genes, ras; Hepatocytes; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; NIH 3T3 Cells; Spleen; Tumor Burden | 2006 |
Inhibition of chitin synthases and antifungal activities by 2'-benzoyloxycinnamaldehyde from Pleuropterus ciliinervis and its derivatives.
Topics: Acrolein; Aminoglycosides; Antifungal Agents; Benzoates; Candida; Chitin Synthase; Cryptococcus neoformans; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Structure; Plant Components, Aerial; Plant Extracts; Polygonaceae; Pyrimidine Nucleosides | 2007 |
The activity of 2'-benzoyloxycinnamaldehyde against drug-resistant cancer cell lines.
Topics: Acrolein; Antineoplastic Agents; Apoptosis; Benzoates; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Neoplasms; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species | 2007 |
Plasma pharmacokinetics and metabolism of the antitumour drug candidate 2'-benzoyloxycinnamaldehyde in rats.
Topics: Acrolein; Animals; Antineoplastic Agents; Benzoates; Biotransformation; Chromatography, High Pressure Liquid; Male; Metabolic Clearance Rate; Microsomes, Liver; Molecular Structure; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry | 2009 |
Structure-activity analysis of 2'-modified cinnamaldehyde analogues as potential anticancer agents.
Topics: Acrolein; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Benzoates; Cell Line, Tumor; Cinnamates; Drug Design; Humans; Proteasome Endopeptidase Complex; Structure-Activity Relationship | 2009 |
2'-Benzoyloxycinnamaldehyde inhibits tumor growth in H-ras12V transgenic mice via downregulation of metallothionein.
Topics: Acrolein; Animals; Antineoplastic Agents; Benzoates; Cell Line, Tumor; Down-Regulation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms, Experimental; Male; Metallothionein; Mice; Mice, Transgenic; Oligonucleotide Array Sequence Analysis; Plant Components, Aerial; Polygonaceae; Protein Isoforms; ras Proteins; RNA, Messenger; Tumor Burden | 2009 |
Transport and metabolism of the antitumour drug candidate 2'-benzoyloxycinnamaldehyde in Caco-2 cells.
Topics: Acrolein; Aldehyde Oxidase; Antineoplastic Agents; Benzoates; Biological Transport; Caco-2 Cells; Coumaric Acids; Enzyme Inhibitors; Esterases; Humans; Hydrolysis; Metabolic Networks and Pathways; Methanol; Oxidation-Reduction; Time Factors | 2009 |
Differential antiproliferation effect of 2'-benzoyloxycinnamaldehyde in K-ras-transformed cells via downregulation of thiol antioxidants.
Topics: Acrolein; Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Benzoates; Cell Cycle; Cell Line; Cell Proliferation; Cell Transformation, Neoplastic; Down-Regulation; Genes, ras; Glutamate-Cysteine Ligase; Glutathione; Metallothionein; Microtubule-Associated Proteins; NF-E2-Related Factor 2; Protein Deglycase DJ-1; Rats; Reactive Oxygen Species | 2011 |
2'-Benzoyloxycinnamaldehyde-mediated DJ-1 upregulation protects MCF-7 cells from mitochondrial damage.
Topics: Acrolein; Antineoplastic Agents; Benzoates; Cell Cycle; Cell Line, Tumor; Cell Survival; Gene Silencing; Humans; Intracellular Signaling Peptides and Proteins; Membrane Potential, Mitochondrial; Mitochondria; Oncogene Proteins; Protein Deglycase DJ-1; RNA, Small Interfering; Up-Regulation | 2012 |
2'-Benzoyloxycinnamaldehyde inhibits nitric oxide production in lipopolysaccharide-stimulated RAW 264.7 cells via regulation of AP-1 pathway.
Topics: Acrolein; Animals; Anti-Inflammatory Agents; Benzoates; Cell Line; Inflammation; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Nitrites; Transcription Factor AP-1 | 2012 |
Early growth response protein 1 upregulation and nuclear translocation by 2'-benzoyloxycinnamaldehyde induces prostate cancer cell death.
Topics: Acrolein; Activating Transcription Factor 3; Active Transport, Cell Nucleus; Antineoplastic Agents; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Benzoates; Cell Cycle Proteins; Cell Line, Tumor; Cell Nucleus; Cell Survival; Early Growth Response Protein 1; Gene Expression; Gene Knockdown Techniques; Glutathione; Growth Differentiation Factor 15; Humans; Karyopherins; Male; Nuclear Proteins; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; RNA, Small Interfering; Up-Regulation | 2013 |
Induction of tumor cell death through targeting tubulin and evoking dysregulation of cell cycle regulatory proteins by multifunctional cinnamaldehydes.
Topics: Acrolein; Antineoplastic Agents; Apoptosis; Benzoates; Caspase 3; Cell Cycle Proteins; Cell Line, Tumor; Fungal Proteins; G2 Phase Cell Cycle Checkpoints; Gene Expression; Histones; Humans; Poly(ADP-ribose) Polymerases; Tubulin; Virulence Factors | 2012 |
2-Hydroxycinnamaldehyde inhibits the epithelial-mesenchymal transition in breast cancer cells.
Topics: Acrolein; Animals; Antineoplastic Agents; Benzoates; Breast Neoplasms; Cadherins; Cell Line, Tumor; Cell Movement; Cell Survival; Cinnamates; Disease Models, Animal; Epidermal Growth Factor; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Differentiation Protein 1; MCF-7 Cells; Mice; Neoplasm Metastasis; Snail Family Transcription Factors; Transcription Factors; Transcriptional Activation; Wnt Signaling Pathway | 2013 |
EGR1-dependent PTEN upregulation by 2-benzoyloxycinnamaldehyde attenuates cell invasion and EMT in colon cancer.
Topics: Acrolein; Animals; Benzoates; Cadherins; Cell Line, Tumor; Cell Movement; Colonic Neoplasms; Early Growth Response Protein 1; Epithelial-Mesenchymal Transition; Female; Humans; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Up-Regulation | 2014 |
Dual pH-sensitive oxidative stress generating micellar nanoparticles as a novel anticancer therapeutic agent.
Topics: Acrolein; Animals; Antineoplastic Agents; Apoptosis; Benzoates; Cell Survival; Enzyme Inhibitors; Heme Oxygenase-1; Humans; Hydrogen-Ion Concentration; Mice; Mice, Nude; Micelles; Nanoparticles; Oxidative Stress; Polymers; Protoporphyrins; Reactive Oxygen Species; Xenograft Model Antitumor Assays | 2014 |
DJ-1 Protects Breast Cancer Cells Against 2'-Benzoyloxycinnamaldehyde-induced Oxidative Stress Independent of Nrf2.
Topics: Acrolein; Benzoates; Breast Neoplasms; Cytoprotection; Female; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; MCF-7 Cells; Mitochondria; NF-E2-Related Factor 2; Oncogene Proteins; Oxidative Stress; Protein Deglycase DJ-1; Signal Transduction | 2015 |
Combined treatment with 2'-hydroxycinnamaldehyde and temozolomide suppresses glioblastoma tumorspheres by decreasing stemness and invasiveness.
Topics: Acrolein; Adenosine Triphosphate; Animals; Antineoplastic Agents; Benzoates; Cell Line, Tumor; Cell Survival; Cinnamates; Drug Therapy, Combination; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Neoplastic Stem Cells; Temozolomide; Tissue Scaffolds | 2019 |